12 June 2025 : Clinical Research
Platelet-to-Lymphocyte Ratio as a Predictor of Atrial Fibrillation in STEMI Patients
Tingting Li BCDEF 1, Qi Zhang BCDEF 2, Xiaosong Gu BE 3, Yifei Tao AEF 4*, Jiayu Yin ABCDEF 3DOI: 10.12659/MSM.948334
Med Sci Monit 2025; 31:e948334
Table 2 Treatment of NOAF during hospitalization.
| NOAF (n=53) | |
|---|---|
| Catheter ablation, n(%) | 0 (0.00) |
| Electrical cardioversion, n(%) | 1 (1.89) |
| Anti-arrhythmia, n(%)* | 37 (69.81) |
| Anticoagulants, n(%) | 19 (35.85) |
| NOAF – new-onset atrial fibrillation. * Except for β-blockers. | |